These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8483812

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Liver angiotensin II receptors in the rat: binding properties and regulation by dietary Na+ and angiotensin II.
    Sernia C, Sinton L, Thomas WG, Pascoe W.
    J Endocrinol; 1985 Jul; 106(1):103-11. PubMed ID: 2991407
    [Abstract] [Full Text] [Related]

  • 27. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
    Olins GM, Corpus VM, McMahon EG, Palomo MA, Schuh JR, Blehm DJ, Huang HC, Reitz DB, Manning RE, Blaine EH.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
    [Abstract] [Full Text] [Related]

  • 28. Binding and degradation studies on angiotensin II.
    Grover AK, Kwan CY, Kostka P, Shephard SM, Daniel EE.
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1203-8. PubMed ID: 6498633
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.
    Chiu AT, McCall DE, Aldrich PE, Timmermans PB.
    Biochem Biophys Res Commun; 1990 Nov 15; 172(3):1195-202. PubMed ID: 2244903
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
    Crawford KW, Frey EA, Cote TE.
    Mol Pharmacol; 1992 Jan 15; 41(1):154-62. PubMed ID: 1310139
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.